Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Expert Review of Neurotherapeutics|February 2, 2013
Endocannabinoid system modulator use in everyday clinical practice in the UK and SpainAntonio García-MerinoCells|October 23, 2021
Bruton's Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis TherapyAntonio García-MerinoExpert Review of Neurotherapeutics|October 11, 2016
Anti-CD20 monoclonal antibodies in multiple sclerosisIrene Moreno Torres, Antonio García-MerinoPrehospital and Disaster Medicine|April 13, 2004
Terrorism in Spain: emergency medical aspectsLuis García-Castrillo Riesgo, Antonio García MerinoRevista De Neurologia|June 22, 2012
[Basic mechanisms of action of fingolimod in relation to multiple sclerosis]J Antonio García-Merino, Antonio J SánchezNanomaterials (Basel, Switzerland)|January 22, 2024
The Synthesis of Sponge-like V2O5/CNT Hybrid Nanostructures Using Vertically Aligned CNTs as TemplatesMatías Picuntureo, José Antonio García-Merino, Roberto Villarroel, et al.Biochemical Pharmacology|September 30, 2006
R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptorAntonio J Sánchez, Paz González-Pérez, Ismael Galve-Roperh, et al.Journal of Neuropathology and Experimental Neurology|October 6, 2007
Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitisElisabet Reyes-Irisarri, Antonio J Sánchez, Juan Antonio García-Merino, et al.Journal of Neuroimmunology|September 27, 2005
Rolipram impairs NF-kappaB activity and MMP-9 expression in experimental autoimmune encephalomyelitisAntonio J Sánchez, Carmen Puerta, Sara Ballester, et al.Pageof 5